Plasma PIVKA-II levels in epileptic patients.
Origuchi
Y
Y
Motohara
K
K
Endo
F
F
Matsuda
I
I
D000293:Adolescent; D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects*; D015415:Biomarkers; D002648:Child; D002675:Child, Preschool; D004827:Epilepsy / Q000097:blood* / Q000188:drug therapy; D005260:Female; D006474:Hemorrhagic Disorders / Q000175:diagnosis; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D011498:Protein Precursors / Q000009:adverse effects*; D011516:Prothrombin / Q000009:adverse effects*; D014813:Vitamin K Deficiency / Q000139:chemically induced*
D000927:Anticonvulsants; D015415:Biomarkers; D011498:Protein Precursors; C008208:acarboxyprothrombin; D011516:Prothrombin